Breast cancer is one of the most threatening diseases for women. It is found that BRCA2 gene plays a significant role in breast cancer, provided that mutations occurred. The objective of this study is to determine whether the bioinformatics approach could provide the gene networking, molecular simulation, and computational metabolomics information to shed the relation between BRCA2 gene mutation with breast cancer progression. The methods are utilizing molecular simulation tools to comprehend the biochemical interaction of BRCA2 gene with other oncogenic genes. Lastly, the molecular docking tool is devised to provide the molecular interactions information. It could be implied that the Computer-Aided Drug Design (CADD)-based in silico transc...
Objective: Cancer ovary is one of the fatal gynecologic malignancies worldwide. Since breast cancer ...
Breast cancer is a major malignant disease affecting females worldwide. It is the most common invasi...
A large number of rare sequence variants of unknown clinical significance have been identified in th...
Breast cancer is one of the most threatening diseases for women. It is found that BRCA2 gene plays a...
Breast cancer is one of the most threatening diseases for women. It is found that BRCA2 gene plays a...
Breast cancer is the second leading cause of cancer death in women only next to lung cancer. In norm...
BRCA1/2 are breast cancer susceptibility genes that are involved in DNA repair and transcriptional c...
Breast cancer type 2 susceptibility (BRCA2) protein plays a crucial role in DNA double-strand breaks...
Background and Purpose: BRCA1 and BRCA2 are major hereditary breast/ovarian cancer predisposing gene...
Background and Purpose: BRCA1 and BRCA2 are major hereditary breast/ovarian cancer predisposing gene...
Objective: Breast Cancer 1 (BRCA1), Early Onset and Breast Cancer 2, Early Onset (BRCA2) genes are i...
Objective: Breast cancer is most common cancer type to women with 5, 00,000 deaths in every year wor...
Recent developments in clinical patient-based personalized genomics explored a variety of biomarkers...
BRCAness has important implications in the management and treatment of patients with breast and ovar...
Homologous recombination (HR) is the primary pathway for repairing double-strand DNA breaks implicat...
Objective: Cancer ovary is one of the fatal gynecologic malignancies worldwide. Since breast cancer ...
Breast cancer is a major malignant disease affecting females worldwide. It is the most common invasi...
A large number of rare sequence variants of unknown clinical significance have been identified in th...
Breast cancer is one of the most threatening diseases for women. It is found that BRCA2 gene plays a...
Breast cancer is one of the most threatening diseases for women. It is found that BRCA2 gene plays a...
Breast cancer is the second leading cause of cancer death in women only next to lung cancer. In norm...
BRCA1/2 are breast cancer susceptibility genes that are involved in DNA repair and transcriptional c...
Breast cancer type 2 susceptibility (BRCA2) protein plays a crucial role in DNA double-strand breaks...
Background and Purpose: BRCA1 and BRCA2 are major hereditary breast/ovarian cancer predisposing gene...
Background and Purpose: BRCA1 and BRCA2 are major hereditary breast/ovarian cancer predisposing gene...
Objective: Breast Cancer 1 (BRCA1), Early Onset and Breast Cancer 2, Early Onset (BRCA2) genes are i...
Objective: Breast cancer is most common cancer type to women with 5, 00,000 deaths in every year wor...
Recent developments in clinical patient-based personalized genomics explored a variety of biomarkers...
BRCAness has important implications in the management and treatment of patients with breast and ovar...
Homologous recombination (HR) is the primary pathway for repairing double-strand DNA breaks implicat...
Objective: Cancer ovary is one of the fatal gynecologic malignancies worldwide. Since breast cancer ...
Breast cancer is a major malignant disease affecting females worldwide. It is the most common invasi...
A large number of rare sequence variants of unknown clinical significance have been identified in th...